An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Clinical trial NCT06655519 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06655519
- Sponsor
- Peking University People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-25
- Primary completion
- 2028-07-05
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.